Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline. In this Contemporary Pediatrics interview, ...

With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider. Influenza Vaccine Live (FluMist; AstraZeneca) is now FDA ...

In a recently-published study, results demonstrated that residence in low-income, low-food access neighborhoods in early life was linked to higher subsequent child body mass index (BMI) and higher ...

The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC. The FDA has approved the first drug to treat ...

First-generation antihistamine prescriptions were linked to a 22% higher seizure risk in young children, especially those aged 6 to 24 months, according to recent findings. First-generation ...

Previous research has associated poor health outcomes and increased health care use with household food insecurity (HFI), which can be dependent on context and environmental stressors, such as ...

The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...

Preadolescent sleep disturbances were linked to an increased risk of suicidal thoughts and behaviors in early adolescence, highlighting sleep as a key intervention target. Findings from a study ...

Pediatric patients treated with Janus kinase inhibitors (JAKi) reporting adverse events (AEs) report higher numbers of lymphatic and blood disorders, recent findings suggest, whereas adults aged 18 ...

What are common misconceptions regarding the timing of therapy initiation and discontinuation? What has research shown regarding outcomes for initiating therapy before age 7 years or discontinuing ...

How do you address bone density concerns and spermatogenesis in a male patient with CPP?

The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing ...